Tarveda Therapeutics

About Tarveda Therapeutics

Tarveda Therapeutics develops miniature drug conjugates that target solid tumors by delivering cytotoxic agents directly to cancer cells, minimizing damage to healthy tissue. This approach aims to improve treatment efficacy and reduce side effects for patients with various types of solid tumors.

Tarveda Therapeutics develops miniature drug conjugates that target solid tumors by delivering cytotoxic agents directly to cancer cells, minimizing damage to healthy tissue. This approach aims to improve treatment efficacy and reduce side effects for patients with various types of solid tumors.

What does Tarveda Therapeutics do?

Tarveda Therapeutics develops miniature drug conjugates that target solid tumors by delivering cytotoxic agents directly to cancer cells, minimizing damage to healthy tissue. This approach aims to improve treatment efficacy and reduce side effects for patients with various types of solid tumors.

Where is Tarveda Therapeutics located?

Tarveda Therapeutics is based in Watertown, United States.

When was Tarveda Therapeutics founded?

Tarveda Therapeutics was founded in 2011.

Location
Watertown, United States
Founded
2011
Employees
6 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

Tarveda Therapeutics

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

Tarveda Therapeutics develops miniature drug conjugates that target solid tumors by delivering cytotoxic agents directly to cancer cells, minimizing damage to healthy tissue. This approach aims to improve treatment efficacy and reduce side effects for patients with various types of solid tumors.

tarvedatx.com2K+
Founded 2011Watertown, United States

Funding

No funding information available.

Team (5+)

No team information available.

Company Description

Tarveda Therapeutics develops miniature drug conjugates that target solid tumors by delivering cytotoxic agents directly to cancer cells, minimizing damage to healthy tissue. This approach aims to improve treatment efficacy and reduce side effects for patients with various types of solid tumors.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.
Tarveda Therapeutics | StartupSeeker